Gabriella Miller Kids First Act 2.0 Cosponsors 86


Below are some good points to keep in mind when talking or writing about HR 623 – The Gabriella Miller Kids First Research Act 2.0:

Congressman Tom Cole (R-OK04), joined Congresswoman Jennifer Wexton (D-VA10) who introduced this bipartisan legislation (HR 623) in the US House and Senators Tim Kaine (D-VA) and Jerry Moran (R-KS) also introduced a companion bipartisan bill (S 1521) in the US Senate. Both bills take the penalties collected by the U.S. Securities and Exchange Commission (SEC) from pharmaceutical, cosmetic, food supplement, and medical device companies that violate the existing Foreign Corrupt Practices Act (FCPA) and redirects them to critical rare pediatric disease research.

Cosponsors include more than 80 Representatives and 7 Senators . As of this writing, there are over 300 foundations and organizations including the Alliance for Childhood Cancer and more than 1,600 advocates covering all 50 states, who have signed a letter of support to the House and Senate for this new bill.  Your support is needed to continue to build upon established, proven methods of research, data collection and data sharing that will lead to more refined diagnostic capabilities and ultimately more targeted therapies.  These ivery successful programs were put in place in 2014 with the first bill which sunsets in 2024.

With The Gabriella Kids First Research Act 2.0, again with non-taxpayer funding, we will be able to expand this program to develop a truly comprehensive shared-data resource for scientists researching the majority of pediatric cancers and structural birth defects, and support development of computational tools to analyze these very large, complex genomic, and clinical data sets.

FundingGMKF2_edited-1Here’s how the Gabriella Miller Kids First Act 2.0 will create more research for childhood cancer and rare pediatric diseases: Under the Food, Drug, and Cosmetic Act, related companies that violate its existing laws must pay fines. Under the new Kids First 2.0 Act, the fines are collected and transferred to the National Institutes of Health (NIH), which funds the GMKF Pediatric Research Initiative Fund.  The new Kids First Act 2.0 is expected to generate much more funding.  The new legislation  would redirect penalties levied against companies regulated by the U.S. Securities and Exchange Commission (SEC) for violating the Foreign Corrupt Practice Act (FCPA). The funds would be transferred to the Kids First Pediatric Research Program (Kids First) at the National Institutes of Health (NIH). There have been consistent and large civil sanctions leveraged  since 2013 – hundreds of millions of dollars from six violations against pharmaceutical companies alone!

After talking to the Representative’s office, they may want to have a “one-pager” sent to them.  Please send them this one-pager link which will give them much more information: